Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

2024

Base Year

2018-2024

Historical Year

2025-2034

Forecast Year

Global Controlled Release Drug Delivery Market Outlook

The global controlled release drug delivery market size was valued at USD 54.8 billion in 2024, driven by the emphasis on reducing medication related side-effects across the globe. The market is expected to grow at a CAGR of 10.4% during the forecast period of 2025-2034, with the values likely to rise from USD 60.5 billion in 2025 to USD 134 billion by 2034.

Controlled Release Drug Delivery: Introduction

Controlled release drug delivery is done to achieve the optimal drug-serum concentration by releasing drugs in a rational programed rate. This system can allow reduced drug administration, better drug absorption, and lesser side effects. It can enhance the efficacy, safety, and convenience of drug therapy in patients. Controlled release drug delivery is commonly done via oral and transdermal administration, among others.

Global Controlled Release Drug Delivery Market Analysis

Traditional drug formulations are often associated with unwanted side effects, painful administration, infusion related toxicity, immunocompromised host, and antimicrobial resistance. To address such concerns, researchers have diverted towards new methods of drug administration, leading to accelerated controlled release drug delivery market value.

Recently, electrospun nanofibers have emerged as a new advancement in controlled drug release market strategies. Most of the benefits lie in the cost, easy programmability, versatility, and scalability of the nanofibers. They can be easily customized based on orientation, size, and the nature of polymers.

The controlled release drug delivery market growth is driven by the increasing engagement of impactful healthcare companies to develop better alternative for patients. AstraZeneca has recently come up with several new options to make drug administration convenient. Biodegradable implants are a prime example. PLGA (poly lactic-co-glycolic acid) and polycaprolactone are being used to store medicines and release them as per the diffusion and degradation characteristics of the particles.

Another method is the atomic layer deposition of metal oxides. It is a dry, metal oxide film deposition that allows sustained release for prolonged period, followed by nano shell formation on the surface. The Silica particle-based controlled release is also being investigated and may be a preferred alternative in the future.

Global Controlled Release Drug Delivery Market Segmentation

Market Breakup by Technology

  • Wurster Technique
  • Coacervation
  • Micro Encapsulation
  • Implants
  • Transdermal
  • Targeted Delivery
  • Others

Market Breakup by Mechanism

  • Polymer Based Systems
  • Micro Reservoir Partition Controlled Drug Delivery Systems
  • Feedback Regulated Drug Delivery Systems
  • Activation-modulated Drug Delivery Systems
    • Osmotic Pressure Activated
    • Hydrodynamic Pressure Activated
    • Vapor Pressure Activated
    • Mechanically Activated
    • Magnetically Activated
  • Chemically Activated
    • pH Activated
    • Hydrolysis Activated
    • Enzyme Activated

Market Breakup by Applications

  • Metered Dose Inhalers
  • Injectable
  • Transdermal and Ocular Patches
  • Infusion Pumps
  • Oral Controlled-drug Delivery Systems
  • Drug Eluting Stents

Market Breakup by End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Cancer Research Institutes
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Controlled Release Drug Delivery Market Overview

The controlled release drug delivery market share was dominated by the United States during the historical period. The growing market size can be attributed to a well-developed healthcare infrastructure and a strong focus on research and development. With significant investments in advanced technologies, the regulatory bodies pertaining to the area also play a critical role in maintaining the efficacy of drug administration.

Europe, having prominent research and academic institutions, along with key healthcare companies, is a major player in the market. The market growth is highly driven by the growing partnerships between research institutions and healthcare companies, aimed at offering better drug delivery technologies to the patients.

With rising geriatric population and high incidence of chronic diseases, Asia Pacific countries are experiencing high controlled release drug delivery market demand. Factors like rising infrastructure development, disposable incomes, and growing awareness of advanced treatment options are further fueling the market growth. Private sectors are also playing a huge part in improving the healthcare ecosystem and fostering innovative drug delivery systems.

Global Controlled Release Drug Delivery Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • GlaxoSmithKline plc (GSK)
  • Merck & Co., Inc.
  • Bristol Myers Squibb Company
  • Eli Lilly and Company
  • Alkermes plc.
  • UCB S.A.
  • Vectura Group plc.
  • Coating Place, Inc.
  • Skyepharma Production S.A.
  • Capsugel
  • Depomed, Inc.
  • Aradigm Corporation

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2018-2024
Forecast Period 2025-2034
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Technology
  • Mechanism
  • Applications
  • End User
  • Region
Breakup by Technology
  • Wurster Technique
  • Coacervation
  • Micro Encapsulation
  • Implants
  • Transdermal
  • Targeted Delivery
  • Others
Breakup by Mechanism
  • Polymer Based Systems
  • Micro Reservoir Partition Controlled Drug Delivery Systems
  • Feedback Regulated Drug Delivery Systems
  • Activation-modulated Drug Delivery Systems
  • Chemically Activated
Breakup by Applications
  • Metered Dose Inhalers
  • Injectable
  • Transdermal and Ocular Patches
  • Infusion Pumps
  • Oral Controlled-drug Delivery Systems
  • Drug Eluting Stents
Breakup by End User
  • Hospitals 
  • Ambulatory Surgical Centers
  • Cancer Research Institutes
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • GlaxoSmithKline plc (GSK)
  • Merck & Co., Inc.
  • Bristol Myers Squibb Compan
  • Eli Lilly and Company
  • Alkermes plc.
  • UCB S.A.
  • Vectura Group plc.
  • Coating Place, Inc.
  • Skyepharma Production S.A
  • Capsugel
  • Depomed, Inc.Aradigm 
  • Aradigm Corporati

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of about USD 54.8 billion in 2024, driven by the focus on reducing medication associated side effects across the globe.

The market is anticipated to grow at a CAGR of 10.4% during the forecast period of 2025-2034, likely to reach a market value of USD 134 billion by 2034.

The market demand is driven by the benefits of controlled release drug delivery systems. It can help in the drug delivery optimisation, along with maintaining therapeutic levels for a prolonged time.

The current market trend revolves around the rising application of biodegradable implants in controlled release drug delivery systems. AstraZeneca has started using PLGA (poly lactic-co-glycolic acid) and polycaprolactone to release particles based on the diffusion time.

Based on technology, the market is divided into Wurster technique, coacervation, micro encapsulation, implants, transdermal, and targeted delivery, among others.

It includes polymer-based systems, micro reservoir partition-controlled drug delivery systems, feedback regulated drug delivery systems, activation-modulated drug delivery systems, and chemically activated.

The drug delivery finds wide applications in metered dose inhalers, injectable, transdermal and ocular patches, infusion pumps, oral controlled-drug delivery systems, and drug eluting stents.

Major end users include hospitals, ambulatory surgical centers, and cancer research institutes, among others.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.

Key players involved in the market are Johnson & Johnson, Novartis AG, Pfizer Inc., GlaxoSmithKline plc (GSK), Merck & Co., Inc., Bristol Myers Squibb Company, Eli Lilly and Company, Alkermes plc., UCB S.A., Vectura Group plc., Coating Place, Inc., Skyepharma Production S.A., Capsugel, Depomed, Inc., and Aradigm Corporation.

Datasheet

10 % Off

USD

3,299

2,969

Single User License

10 % Off

USD

5,499

4,949

Five User License

15 % Off

USD

6,999

5,949

Corporate License

15 % Off

USD

8,199

6,969

Datasheet

One User

USD 3,299

USD 2,969

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 5,499

USD 4,949

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 8,199

USD 6,969

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124